Actively Recruiting
A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer
Led by Sixth Affiliated Hospital, Sun Yat-sen University · Updated on 2026-01-06
200
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Robotic surgical systems provide notable advantages including enhanced dexterity, a magnified three-dimensional high-definition view, and high-resolution imaging, thereby improving operative stability and precision. These features make robotic systems particularly suitable for procedures performed within confined operative spaces. As the breast is a solid organ without a natural cavity, robotic systems demonstrate strong adaptability for breast surgery. Robot-assisted breast-conserving surgery (RABCS) is one of the currently utilized robotic techniques in clinical breast cancer surgery. However, as robotic breast surgery remains in its early stage of development, evidence regarding the clinical outcomes of RABCS remains limited in the literature. Therefore, this study compares the surgical outcomes of endoscopic breast-conserving surgery and robot-assisted breast-conserving surgery in breast cancer patients, aiming to assess and elucidate the clinical value of RABCS.
CONDITIONS
Official Title
A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18 to 80 years
- Pathologically confirmed breast cancer prior to surgery
- Sufficient glandular volume with a tumor-to-breast volume ratio �3C=20%
- A unifocal lesion confined to the glandular tissue
- Clear desire for breast conservation and willingness to undergo R-BCS or E-BCS
- No evidence of distant metastasis, no involvement of the skin or chest wall
- Eligibility for standard postoperative radiotherapy
You will not qualify if you...
- Diffuse suspicious lesions or microcalcifications unlikely to achieve adequate negative margins or good aesthetic outcomes with surgery
- Bilateral breast cancer or inflammatory breast cancer
- Need for additional concurrent surgical procedures after neoadjuvant therapy
- Unable to tolerate general anesthesia or surgery
- Contraindications to radiotherapy or prior chest wall irradiation, pregnancy- or lactation-associated breast cancer
- Refusal to undergo R-BCS or E-BCS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
H
Haiyan Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here